The tissue factor activity in plasma in patient with DIC
Iijima, K.; Fukuda, C.; Nakamura, K.
Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 86: 142-148
1990
ISSN/ISBN: 0047-1860 PMID: 2232235 Document Number: 355311
Document emailed within 1 workday
Related Documents
He, W.J.; Hu, Y.; Zhang, X.P.; Hong, M.; Guo, T.; Wei, W.N.; Song, S.J. 2008: Activated protein C ratio, plasma tissue factor activity and activated factor VIi in Chinese patients with coronary heart disease European Journal of Medical Research 13(2): 47-51Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Almus, F.E.; Rao, L.V.; Rapaport, S.I. 1989: Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells Thrombosis and Haemostasis 62(4): 1067-1073
Nieuwenhuys, C.M.; Feijge, M.A.; Béguin, S.; Heemskerk, J.W. 2000: Monitoring hypocoagulant conditions in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma Thrombosis and Haemostasis 84(6): 1045-1051
Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Ihle, J.N.; Keller, J.; Oroszlan, S.; Henderson, L.E.; Copeland, T.D.; Fitch, F.; Prystowsky, M.B.; Goldwasser, E.; Schrader, J.W.; Palaszynski, E.; Dy, M.; Lebel, B. 1983: Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity Journal of Immunology 131(1): 282-287
Drozdz, H. 1971: Effect of hydrocortisone on the activity of plasma and hepatic tissue enzymes. I. Leucylaminopeptidase (LAP) and glycylaminopeptidase (GAP) activity in experimental liver cirrhosis and mechanical jaundice in rats Przeglad Lekarski 28(12): 765-770
Egberg, N.; Gallimore, M.J. 1983: Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical material Advances in Experimental Medicine and Biology 156: 1109-1117
Lu, G-yuan.; Shen, L.; Wang, Z-yue.; Guo, X-fang.; Bai, X.; Su, J.; Ruan, C-geng. 2008: Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chinese Medical Journal 121(2): 133-136
Christensen, A. 1974: Hormone and enzyme assays in pregnancy. I. Studies on the placental and the tissue cystine-aminopeptidase activity in peripheral plasma from non-pregnant and pregnant women, and in plasma from the umbilical cord Acta Endocrinologica 76(1): 189-200
Lindhout, T.; Franssen, J.; Willems, G. 1995: Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor Thrombosis and Haemostasis 74(3): 910-915
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Béguin, S.; Lindhout, T.; Hemker, H.C. 1989: The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin Thrombosis and Haemostasis 61(1): 25-29
Miyazaki, S. 1992: Clinical study of the epidermal growth factor contents in urine, plasma and tissue from the patients with urological diseases Hinyokika Kiyo. Acta Urologica Japonica 38(8): 919-924
Ikeda, K.; Nagasawa, K.; Horiuchi, T.; Tsuru, T.; Nishizaka, H.; Niho, Y. 1997: C5a induces tissue factor activity on endothelial cells Thrombosis and Haemostasis 77(2): 394-398
Pastorova, V.E.; Umarova, B.A. 1975: Change in factor XIII activity in plasma during thrombocyte aggregation Biulleten' Eksperimental'noi Biologii i Meditsiny 80(7): 14-17
Robinson, D.S.; Wing, D.R. 1970: Regulation of adipose tissue clearing factor lipase activity Hormone and Metabolic Research 2(Suppl 2): 41-46
Cucuianu, M.; Trif, I.; Roman, S.; Manasia, M.; Spînu, C.; Cristea, A. 1989: Plasma von Willebrand factor antigen and activity and platelet aggregability in patients with proteinuria Medecine Interne 27(4): 263-271
Jurina, K.; Gropp, F.; Oechtering, G. 1996: The determination of von Willebrand factor activity in the plasma of dogs. 1. Experimental evaluation and methods Tierarztliche Praxis 24(6): 616-620